Itemoids

You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Merck

since

auto-detected in 36 stories

4 days ago

Merck said on ⁠Monday it will split its human-health ​business into ​two ​divisions, separating its cancer franchise from ⁠its non-oncology ‌medicines.

24 days ago

Merck posted a modest 2026 outlook that fell short of estimates, as it prepares for some drugs to go off patent later this year and face generic competition.
These are the stocks posting the largest moves in early trading.
Merck will report its earnings on Tuesday, offering insights into how its agreement to lower the price of its diabetes drug has impacted its business.

62 days ago

Wall Street's most overbought stocks for the last full trading week of the year included Merck & Co. and S&P Global.

80 days ago

There's hope for U.S. cattle ranchers in the battle to stop the spread of screwworm at a time of decimated herds with the FDA approving a new Merck treatment.

3 months ago

Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, the companies said on Friday, gaining access to an experimental drug for flu prevention.
San Diego company’s lead drug is a potential alternative to vaccines for vulnerable patients
Pharma groups boost financial outlooks as revenues from flagship medicines like Zepbound and Keytruda leap
These are some of the stocks posting the largest moves in early trading.

page 1 of 4 last →|